The surge in demand for corneal implants stems mainly from
the rise in instances of corneal blindness, eye injuries, and
conditions like ocular hypertension (glaucoma). Moreover, the
growing collaboration among industry stakeholders to innovate in
corneal implant technology, alongside the limited availability of
cornea donors, is anticipated to drive the expansion of the corneal
implant market from 2024 to 2030.
LAS
VEGAS, April 23, 2024 /PRNewswire/ --
DelveInsight's Corneal Implant Market Insights report
provides the current and forecast market analysis, individual
leading corneal implant companies' market shares, challenges,
corneal implant market drivers, barriers, trends, and key market
corneal implant companies in the market.
Key Takeaways from the Corneal Implant Market Report
- As per DelveInsight estimates, North
America is anticipated to dominate the global corneal
implant market during the forecast period.
- Notable corneal implant companies such as EyeYon, AJL
Ophthalmic S.A., KeraMed, Inc., Aurolab, CorneaGen, Presbia PLC,
LinkoCare Life Sciences AB, MEDIPHACOS, Cornea Biosciences,
Advancing Sight Network, Corneat Vision, DIOPTEX, and several
others, are currently operating in the corneal implant market.
- In July 2022, Acufocus
received FDA approval for AcuFocus' IC-8 Apthera. IC-8 Apthera is
indicated for the treatment of cataract patients.
- In July 2019, CorneaGen
received USD 37 million in funding
for the advanced development of Cornea Cell Therapy.
To read more about the latest highlights related to the corneal
implant market, get a snapshot of the key highlights entailed in
the Global Corneal Implant Market Report
Corneal Implant Overview
Corneal implants, also known as corneal inlays, are innovative
devices designed to correct refractive errors such as presbyopia, a
condition where the eye's ability to focus on nearby objects
diminishes with age. These tiny implants are placed within the
cornea, the transparent front part of the eye, to enhance its
optical properties and improve vision. Unlike traditional
eyeglasses or contact lenses, corneal implants offer a more
permanent solution with minimal maintenance, providing individuals
with clear vision and freedom from dependency on corrective
eyewear.
The procedure for inserting corneal implants is relatively quick
and minimally invasive, often performed on an outpatient basis. By
carefully reshaping the cornea's curvature, these implants can
restore near vision, allowing individuals to read, work on
computers, and perform other close-up tasks without difficulty.
With advancements in technology and materials, corneal implants
continue to evolve, offering promising outcomes for those seeking
long-term vision correction without the inconvenience of glasses or
contacts.
Corneal Implant Market Insights
In 2023, North America
dominated the corneal implant market, primarily due to the presence
of key industry players in the region. Favorable reimbursement
policies, heightened research and development efforts focused on
corneal implants, and the escalating burden of corneal blindness
all contribute to this growth trend.
Data from the Centers for Disease Control and Prevention (CDC)
in 2022 revealed that around 6 million Americans experienced vision
loss and 1 million suffered from blindness in 2017. The prevalence
of risk factors like diabetes and hypertension, as highlighted in
the CDC's National Diabetes Statistics Report of 2020, further
exacerbates ocular disorders. With approximately 34.2 million
Americans diagnosed with diabetes in 2020 and another 88 million
displaying pre-diabetic conditions, the demand for corneal implants
is expected to rise as ophthalmic disorders become more
prevalent.
Additionally, North America
benefits from significant product development and partnership
initiatives within the corneal implants sector. Notably, in
July 2022, Carl Zeiss Meditec and
Precise Bio announced a collaboration aimed at developing and
commercializing tissue-based implants, underscoring the region's
dynamic corneal implant market landscape.
To know more about why North
America is leading the market growth in the corneal implant
market, get a snapshot of the Corneal Implant Market
Outlook
Corneal Implant Market Dynamics
The corneal implant market has been witnessing dynamic shifts
driven by technological advancements, the rising prevalence of
eye disorders, and increasing awareness about treatment
options. Technological innovations such as advanced materials,
improved surgical techniques, and customizable implants are
revolutionizing the landscape, offering patients more effective and
tailored solutions. Additionally, the growing aging
population and lifestyle changes leading to conditions
like myopia and astigmatism are fueling demand for corneal implants
globally.
Moreover, strategic collaborations between healthcare
institutions, research organizations, and industry players further
propel market growth. These partnerships facilitate the
development of novel products, streamline regulatory
processes, and expand corneal implant market reach. Furthermore,
the adoption of minimally invasive procedures and
outpatient surgeries is driving market expansion by reducing
patient recovery time, lowering healthcare costs, and enhancing
overall patient satisfaction.
However, challenges such as stringent regulatory
requirements, limited reimbursement policies, and the high cost of
advanced implants pose barriers to corneal implant market
growth. Overcoming these hurdles requires concerted efforts from
stakeholders to streamline regulatory frameworks, increase
insurance coverage, and invest in research and development to bring
down costs. Despite these challenges, the corneal implant market is
poised for steady growth as technological innovations continue to
improve treatment outcomes and expand the scope of therapeutic
options for patients with corneal disorders.
Get a sneak peek at the corneal implant market dynamics @
Corneal Implant Market Dynamics Analysis
Report
Metrics
|
Details
|
Coverage
|
Global
|
Study Period
|
2021–2030
|
Corneal Implant Market
CAGR
|
~6%
|
Key Corneal Implant
Companies
|
EyeYon, AJL Ophthalmic
S.A., KeraMed, Inc., Aurolab, CorneaGen, Presbia PLC, LinkoCare
Life Sciences AB, MEDIPHACOS, Cornea Biosciences, Advancing Sight
Network, Corneat Vision, DIOPTEX, among others
|
Corneal Implant Market Assessment
- Corneal Implant Market Segmentation
-
- Corneal Implant Market Segmentation By Procedure:
Endothelial Keratoplasty, Penetrating Keratoplasty, and Others
- Corneal Implant Market Segmentation By Disease:
Keratoconus, Fuchs Dystrophy, Infectious Keratitis, Corneal Ulcers,
and Others
- Corneal Implant Market Segmentation By End User:
Hospitals, Eye Clinics, and Ambulatory Surgical Centers
- Corneal Implant Market Segmentation By Geography:
North America, Europe, Asia-Pacific, and Rest of World
- Porter's Five Forces Analysis, Product Profiles, Case
Studies, KOL's Views, Analyst's View
Which MedTech key players in the corneal implant market are set
to emerge as the trendsetter explore @ Corneal Implant
Companies
Table of Contents
1
|
Report
Introduction
|
2
|
Executive
summary
|
3
|
Regulatory and Patent
Analysis
|
4
|
Key Factors
Analysis
|
5
|
Porter's Five Forces
Analysis
|
6
|
Corneal Implant Market
Layout
|
7
|
Global Company Share
Analysis – Key 3-5 Companies
|
8
|
Corneal Implant
Market Company and Product
Profiles
|
9
|
Project
Approach
|
10
|
About
DelveInsight
|
Interested in knowing the corneal implant market by 2030? Click
to get a snapshot of the Corneal Implant Market
Trends
Related Reports
Fuchs Endothelial Corneal Dystrophy Market
Fuchs Endothelial Corneal Dystrophy Market Insight,
Epidemiology, and Market Forecast – 2034 report delivers an
in-depth understanding of market trends, market drivers, market
barriers, and key FECD companies, including Kowa
Pharmaceuticals, Trefoil Therapeutics, ProQR Therapeutics, and
Emmecell, among others.
Keratoconus Market
Keratoconus Market Insight, Epidemiology, and
Market Forecast – 2032 report delivers an in-depth
understanding of market trends, market drivers, market barriers,
and key keratoconus companies, including Glaukos, Avedro,
Glaukos Corporation, Sooft Italia, Lightmed OptiMed, Peschke
Meditrade GmbH, iVeena Delivery Systems, among others.
Keratitis Market
Keratitis Market Insight, Epidemiology, and Market Forecast –
2032 report delivers an in-depth understanding of market
trends, market drivers, market barriers, and key keratitis
companies, including Merck & Co, Bausch Health, Gilead
Biosciences, Pfizer, and Glenmark Pharmaceuticals, among
others.
Corneal Ulcer Market
Corneal Ulcer Market Insight, Epidemiology, and Market
Forecast – 2032 report delivers an in-depth understanding of
market trends, market drivers, market barriers, and key corneal
ulcer companies, including DompéFarmaceutica, Claris
Biotherapeutics, ReGenTree, LLCR, among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market
Research firm focused exclusively on life sciences. It supports
pharma companies by providing comprehensive end-to-end solutions to
improve their performance.
Contact Us
Shruti
Thakur
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices
Logo:
https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/global-corneal-implant-market-is-expected-to-showcase-a-significant-growth-at-a-cagr-of-6-by-2030--delveinsight-302124036.html
SOURCE DelveInsight Business Research, LLP